79707-34-9

Upstream product

• 96428-50-1 2-carboethoxy-3-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine 
• 24016-03-3 2-amino-3-benzyloxypyridine 

Downstream Products

• 96428-69-2 Pentanoic acid 8-benzyloxy-2-methyl-imidazo[1,2-a]pyridin-3-ylmethyl ester 
• 96428-68-1 3-(acetoxymethyl)-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine 
• 247079-49-8 8-benzyloxy-3-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-imidazo[1,2-a]pyridine 
• 96428-70-5 2,2-Dimethyl-propionic acid 8-benzyloxy-2-methyl-imidazo[1,2-a]pyridin-3-ylmethyl ester 
• 129419-12-1 Nicotinic acid 8-benzyloxy-2-methyl-imidazo[1,2-a]pyridin-3-ylmethyl ester 
• 96428-93-2 3-(aminomethyl)-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine 
• 85333-37-5 3-(isocyanomethyl)-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine 
• 85333-38-6 3-<(formylamino)methyl>-2-methyl-8-(phenylmethoxy)imidazo<1,2-a>pyridine 
• 79707-33-8 Dimethyl-carbamic acid 8-benzyloxy-2-methyl-imidazo[1,2-a]pyridin-3-ylmethyl ester 

Relevant academic research and scientific papers

Skin Lightening Compositions

Compositions and methods for lightening and/or depigmenting skin are provided, the compositions comprising compounds having the structure: or having the structure: as defined herein.

Glucopyranosyl derivatives of 4-aminoquinoline and 2-methylimidazo[1,2- a]-pyridine as potent reversible proton pump inhibitors

Amongst a number of 4-aminoquinoline and 2-methylimidazo[1,2,-a]pyridine derivatives examined 2-[3-butyryl-4-(2-methylphenylamino)quinoline-8- yloxy]ethyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside and 3-ethoxycarbonyl- 2-methylimidazo[1,2-a]pyridine-8-yl

IMIDAZO(1,2-a)(PYRIDAZINES OR PYRAZINES) FOR TREATMENT OF DISEASES RELATED TO BONE LOSS

A method for the treatment of diseases related to loss of bone mass such as osteoporosis, Paget's disease of bone, hy-perparathyroidism, malignant neoplasms causing hypercalcinemia, parodontal diseases and implant-related bone loss comprising administration to a patient suffering thereform an amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Antinuclear Agents. 1. Gastric Antisecretory and Cytoprotective Properties of Substituted Imidazopyridines

A novel class of antinuclear agents, the substituted imidazopyridines, is described.The present compounds are not histamine (H2) receptor antagonists nor are they prostaglandin analoques, yet they exhibit both gastric antisecretory and c

Imidazo[1,2-A]pyridines and use

This invention relates to imidazo[1,2-a]pyridine derivatives which are useful in the treatment of peptic ulcer diseases.